Cited by 33Mesenchymal stem cell researchBone Tissue Engineering MaterialsBone fractures and treatments

Cyasterone accelerates fracture healing by promoting MSCs migration and osteogenesis

Open access
Zhu, Junlang, Liu, Yamei, Chen, Chen, Chen, Hongtai, Huang, Jiewen, Luo, Yiwen, Zhao, Kewei, Chen, Dongfeng +6 more·2021·Journal of Orthopaedic Translation

Abstract

BACKGROUND: Mesenchymal Stem Cells (MSCs) therapy has become a new coming focus of clinical research in regenerative medicine. However, only a small number of implanted MSCs could successfully reach the injured areas. The previous studies have shown that fracture healing time is inversely proportional to concentration of MSCs in injured tissue. METHODS: The migration and osteogenesis of MSCs were assessed by transwell assay and Alizarin Red S staining. Levels of gene and protein expression were checked by qPCR and Western Blot. On the other hand, the enhanced migration ability of MSCs induced by Cyasterone was retarded by CXCR4 siRNA. In addition, the rat model of femoral fracture was established to evaluate the effect of Cyasterone on fracture healing. What's more, we also checked the effect of Cyasterone on mobilisation of MSCs in vivo. RESULTS: The results showed that Cyasteron increased the number of MSCs in peripheral blood. The concentrations of SDF-1α in serum at different time points were determined by ELISA assay. Micro-CT and histological analysis were used to evaluate the fractured femurs.Our results showed that Cyasterone could promote the migration and osteogenesis capacities of MSCs. The fractured femurs healed faster with treatment of Cyasterone. Meanwhile, Cyasterone could significantly increase the level of SDF-1α in rats with femur fracture. CONCLUSION: Cyasterone could promote migration and osteogenesis of MSCs, and most importantly, it could accelerate bone fracture healing.Translational Potential statement: These findings provide evidence that Cyasterone could be used as a therapeutic reagent for MSCs mobilisation and osteogenesis. What's more, it could acclerate fracture healing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jot.2020.11.004

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is a lack of evidence from clinical studies in patients for selective prostaglandin agonists, cyasterone, statins, and anti-sclerostin antibodies as fracture-healing accelerators.

    “Other drugs that have been considered to accelerate fracture healing include selective prostaglandin agonists (111), cyasterone (112), statins, and anti-sclerostin antibodies (113), but there is a lack of evidence from clinical studies in patients.”

    From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [112]

    The Discussion identifies cyasterone as a proposed way to promote fracture healing, and the Abstract Methods describe cell experiments and a rat fracture model, not a study in patients. The paper therefore supports cyasterone’s inclusion among potential accelerators, but it does not establish the broader claim that clinical evidence for cyasterone is lacking. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhu, J., Liu, Y., Chen, C., Chen, H., Huang, J., Luo, Y., Zhao, K., Chen, D., Xu, Z., Li, W., Zhang, X., Xiong, Y., Xu, L., & Wang, B.
Affiliations
  • Guangzhou University of Chinese Medicine (CN)
  • University of Hong Kong (HK)
  • Jiangmen Wuyi Traditional Chinese Medicine Hospital (CN)
  • Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
Corresponding author
  • Xu, Liangliang
  • Wang, Bin
Venue
Journal of Orthopaedic Translation
Publisher
Elsevier BV
Published
2021-05
Volume
28
Pages
28-38
ISSN
2214-031X (ISSN-L)
OpenAlex
W3131272701
Cited by
33
References
35
Citations by year
2026: 5 · 2025: 4 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 4
FWCI
3.37
Type
journal article
Language
en
Open access
Locations
  • Journal of Orthopaedic Translation (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81873326)
  • Natural Science Foundation of Guangdong Province (2017A030313729)
  • Science and Technology Planning Project of Guangdong Province (2017A050506046)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Epidemiology › Bone fractures and treatments
Keywords
cyasterone, fracture healing, mesenchymal stem cells, cell migration, bone formation, SDF-1α, CXCR4, stem cell mobilization, femoral fracture, bone regeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review